Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
Viatris recalled one lot of Xanax XR 3-mg extended-release tablets after failed dissolution testing, with the FDA classifying the action as Class II and reporting no adverse events to date.
Family Medicine/General Practice April 29th 2026
Cleveland Clinic Journal of Medicine (CCJM)
Deprescribing benzodiazepines in patients on long-term stable treatment led to increased mortality along with increases in nonfatal overdoses, suicidal ideation, and emergency department visits.
Psychiatry January 21st 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS